AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 214 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $258,000 | -16.5% | 5,600 | 0.0% | 0.01% | -17.6% |
| Q2 2021 | $309,000 | +6.9% | 5,600 | 0.0% | 0.02% | 0.0% |
| Q1 2021 | $289,000 | +18.9% | 5,600 | 0.0% | 0.02% | +13.3% |
| Q4 2020 | $243,000 | -18.7% | 5,600 | 0.0% | 0.02% | -37.5% |
| Q2 2020 | $299,000 | +12.0% | 5,600 | 0.0% | 0.02% | +26.3% |
| Q4 2019 | $267,000 | -4.3% | 5,600 | 0.0% | 0.02% | -13.6% |
| Q2 2019 | $279,000 | -26.2% | 5,600 | 0.0% | 0.02% | -29.0% |
| Q1 2019 | $378,000 | +46.5% | 5,600 | 0.0% | 0.03% | +29.2% |
| Q4 2018 | $258,000 | -40.3% | 5,600 | 0.0% | 0.02% | -31.4% |
| Q3 2018 | $432,000 | -8.5% | 5,600 | 0.0% | 0.04% | -12.5% |
| Q2 2018 | $472,000 | +3.1% | 5,600 | 0.0% | 0.04% | -2.4% |
| Q1 2018 | $458,000 | +43.1% | 5,600 | 0.0% | 0.04% | +41.4% |
| Q4 2017 | $320,000 | – | 5,600 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Ventures 2007 General Partner LLC | 1,930,369 | $118,428,000 | 83.56% |
| Third Rock Ventures, LLC | 3,070,090 | $188,350,000 | 21.97% |
| Opaleye Management Inc. | 113,500 | $6,963,225,000 | 5.43% |
| BB BIOTECH AG | 1,890,521 | $115,983,000 | 4.72% |
| Eventide Asset Management | 431,600 | $26,479,000 | 3.70% |
| Atika Capital Management LLC | 54,000 | $3,313,000 | 2.55% |
| Cormorant Asset Management, LP | 100,000 | $6,135,000 | 1.26% |
| BRIDGER MANAGEMENT, LLC | 220,099 | $13,503,000 | 0.92% |
| Ghost Tree Capital, LLC | 20,000 | $1,227,000 | 0.67% |
| HAMILTON LANE ADVISORS LLC | 27,544 | $1,690,000 | 0.55% |